{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:41:51Z","timestamp":1793900511023,"version":"4.8.0"},"reference-count":150,"publisher":"BMJ","issue":"11","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Thorax"],"accepted":{"date-parts":[[2025,10,26]]},"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1136\/thorax-2025-223392","type":"journal-article","created":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T17:20:26Z","timestamp":1773076826000},"page":"1108-1118","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Global perspective on pulmonary fibrosis: epidemiology, regional variations, gaps in care and future directions"],"prefix":"10.1136","volume":"81","clinical-trial-number":[{"clinical-trial-number":"nct03727802","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct03727802","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3199-9163","authenticated-orcid":false,"given":"Sahajal","family":"Dhooria","sequence":"first","affiliation":[{"name":"Department of Pulmonary Medicine, Post Graduate Institute of Medical Education and Research, Chandigarh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3994-874X","authenticated-orcid":false,"given":"Yoshikazu","family":"Inoue","sequence":"additional","affiliation":[{"name":"Clinical Research Center, NHO Kinki Chuo Chest Medical Center, Sakai, Osaka, Japan"},{"name":"Internal Medicine, Osaka Anti-Tuberculosis Association Osaka Fukujuji Hospital, Neyagawa, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-5152-0726","authenticated-orcid":false,"given":"Kritarth","family":"Rathi","sequence":"additional","affiliation":[{"name":"Livasa Hospital, Mohali, SAS Nagar, Punjab, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0740-4836","authenticated-orcid":false,"given":"Takayuki","family":"Takimoto","sequence":"additional","affiliation":[{"name":"Internal Medicine, Kinki Chuo Chest Medical Center, Sakai, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,9]]},"reference":[{"key":"2026102613101477000_81.11.1108.1","doi-asserted-by":"publisher","DOI":"10.1136\/thx.43.1.9"},{"key":"2026102613101477000_81.11.1108.2","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00073012"},{"key":"2026102613101477000_81.11.1108.3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271665","article-title":"Incidence, prevalence, and national burden of interstitial lung diseases in India: Estimates from two studies of 3089 subjects","volume":"17","author":"Dhooria","year":"2022","journal-title":"PLoS ONE"},{"key":"2026102613101477000_81.11.1108.4","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.2009-040GL"},{"key":"2026102613101477000_81.11.1108.5","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"2026102613101477000_81.11.1108.6","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.03187-2021","article-title":"Progressive pulmonary fibrosis: an expert group consensus statement","volume":"61","author":"Rajan","year":"2023","journal-title":"Eur Respir J"},{"key":"2026102613101477000_81.11.1108.7","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1164\/rccm.202308-1523ED","article-title":"To Progress or Not to Progress, That Is the Question! Progression in Fibrotic Interstitial Lung Disease","volume":"208","author":"Behr","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026102613101477000_81.11.1108.8","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST"},{"key":"2026102613101477000_81.11.1108.9","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-216732"},{"key":"2026102613101477000_81.11.1108.10","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.150.4.7921471"},{"key":"2026102613101477000_81.11.1108.11","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02419-2016","article-title":"Prevalence and incidence of interstitial lung diseases in a multi-ethnic county of Greater Paris","volume":"50","author":"Duchemann","year":"2017","journal-title":"Eur Respir J"},{"key":"2026102613101477000_81.11.1108.12","doi-asserted-by":"publisher","DOI":"10.1179\/acb.2001.026"},{"key":"2026102613101477000_81.11.1108.13","doi-asserted-by":"publisher","DOI":"10.1023\/B:EJEP.0000017660.18541.83"},{"key":"2026102613101477000_81.11.1108.14","first-page":"64","article-title":"Report on the incidence of interstitial lung diseases in Spain","volume":"21","author":"Xaubet","year":"2004","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026102613101477000_81.11.1108.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2020.05.002"},{"key":"2026102613101477000_81.11.1108.16","first-page":"100864","article-title":"Self-reported asthma prevalence and management in adults in France in 2018: ASTHMAPOP survey","volume":"80","author":"Raherison-Semjen","year":"2021","journal-title":"Respir Med Res"},{"key":"2026102613101477000_81.11.1108.17","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2023.1141372","article-title":"Global trends of interstitial lung diseases from 1990 to 2019: an age-period-cohort study based on the Global Burden of Disease study 2019, and projections until 2030","volume":"10","author":"Zeng","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"2026102613101477000_81.11.1108.18","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02080-2023","article-title":"Mortality trends in idiopathic pulmonary fibrosis in Europe between 2013 and 2018","volume":"64","author":"Gonnelli","year":"2024","journal-title":"Eur Respir J"},{"key":"2026102613101477000_81.11.1108.19","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2023-220887"},{"key":"2026102613101477000_81.11.1108.20","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18147249","article-title":"Mortality Associated with Idiopathic Pulmonary Fibrosis in Northeastern Italy, 2008-2020: A Multiple Cause of Death Analysis","volume":"18","author":"Marcon","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"2026102613101477000_81.11.1108.21","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1590\/s1806-37562017000000035","article-title":"Mortality from idiopathic pulmonary fibrosis: a temporal trend analysis in Brazil, 1979-2014","volume":"43","author":"Algranti","year":"2017","journal-title":"J Bras Pneumol"},{"key":"2026102613101477000_81.11.1108.22","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.chest.2020.08.016","article-title":"Mortality Trends of Idiopathic Pulmonary Fibrosis in the United States From 2004 Through 2017","volume":"159","author":"Jeganathan","year":"2021","journal-title":"Chest"},{"key":"2026102613101477000_81.11.1108.23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1164\/rccm.201905-0958LE","article-title":"Trends in Idiopathic Pulmonary Fibrosis-related Mortality in the United States: 2000-2017","volume":"200","author":"Dove","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2026102613101477000_81.11.1108.24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.chest.2023.11.008","article-title":"Urban-Rural Differences in Idiopathic Pulmonary Fibrosis-Related Mortality Rates in the United States","volume":"165","author":"Jeganathan","year":"2024","journal-title":"Chest"},{"key":"2026102613101477000_81.11.1108.25","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00591-2021","article-title":"Mortality and survival in idiopathic pulmonary fibrosis: a systematic review and meta-analysis","volume":"8","author":"Zheng","year":"2022","journal-title":"ERJ Open Res"},{"key":"2026102613101477000_81.11.1108.26","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201607-1484OC"},{"key":"2026102613101477000_81.11.1108.27","article-title":"Prevalence, incidence, and survival analysis of interstitial lung diseases in Hong Kong: a 16-year population-based cohort study","volume":"42","author":"Ye","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"2026102613101477000_81.11.1108.28","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201504-0818OC"},{"key":"2026102613101477000_81.11.1108.29","doi-asserted-by":"crossref","first-page":"3688","DOI":"10.21037\/jtd-19-4021","article-title":"The interstitial lung disease spectrum under a uniform diagnostic algorithm: a retrospective study of 1,945 individuals","volume":"12","author":"Guo","year":"2020","journal-title":"J Thorac Dis"},{"key":"2026102613101477000_81.11.1108.30","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S2213-2600(13)70191-7","article-title":"Chronic hypersensitivity pneumonitis in patients diagnosed with idiopathic pulmonary fibrosis: a prospective case-cohort study","volume":"1","author":"Morell","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2026102613101477000_81.11.1108.31","doi-asserted-by":"crossref","first-page":"169","DOI":"10.4103\/lungindia.lungindia_186_24","article-title":"Idiopathic nonspecific interstitial pneumonia: Waters remain murky\u2026remember ABCDEFGHI","volume":"41","author":"Dhooria","year":"2024","journal-title":"Lung India"},{"key":"2026102613101477000_81.11.1108.32","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4103\/lungindia.lungindia_75_18","article-title":"Bronchoscopic lung cryobiopsy: An Indian association for bronchology position statement","volume":"36","author":"Dhooria","year":"2019","journal-title":"Lung India"},{"key":"2026102613101477000_81.11.1108.33","doi-asserted-by":"publisher","DOI":"10.4187\/respcare.04488"},{"key":"2026102613101477000_81.11.1108.34","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.alit.2024.06.002","article-title":"Estimated prevalence and incidence of hypersensitivity pneumonitis in Japan","volume":"74","author":"Okamoto","year":"2025","journal-title":"Allergol Int"},{"key":"2026102613101477000_81.11.1108.35","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00477-2016"},{"key":"2026102613101477000_81.11.1108.36","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0413"},{"key":"2026102613101477000_81.11.1108.37","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/MCP.0000000000000940","article-title":"Silica-associated lung disease in developing countries","volume":"29","author":"Dhooria","year":"2023","journal-title":"Curr Opin Pulm Med"},{"key":"2026102613101477000_81.11.1108.38","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.ccm.2023.08.011","article-title":"Fibrotic Pulmonary Sarcoidosis","volume":"45","author":"Nunes","year":"2024","journal-title":"Clin Chest Med"},{"key":"2026102613101477000_81.11.1108.39","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/rheumatology\/keae076","article-title":"Lung imaging patterns in connective tissue disease-associated interstitial lung disease impact prognosis and immunosuppression response","volume":"63","author":"Zheng","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2026102613101477000_81.11.1108.40","doi-asserted-by":"crossref","first-page":"106548","DOI":"10.1016\/j.rmed.2021.106548","article-title":"Sarcoidosis: A nationwide registry-based study of incidence, prevalence and diagnostic work-up","volume":"187","author":"Sikj\u00e6r","year":"2021","journal-title":"Respir Med"},{"key":"2026102613101477000_81.11.1108.41","first-page":"179","article-title":"Sarcoidosis in a racially mixed community","volume":"19","author":"McNicol","year":"1985","journal-title":"J R Coll Physicians Lond"},{"key":"2026102613101477000_81.11.1108.42","first-page":"61","article-title":"The frequency of sarcoidosis in Finland and Hokkaido, Japan. A comparative epidemiological study","volume":"12","author":"Pietinalho","year":"1995","journal-title":"Sarcoidosis"},{"key":"2026102613101477000_81.11.1108.43","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00408-023-00627-5","article-title":"The Relationship Between Sarcoidosis Organ Involvement, Environment, Race, and Genetics: There\u2019s a Signal, But Fine Tuning Is Needed","volume":"201","author":"Judson","year":"2023","journal-title":"Lung"},{"key":"2026102613101477000_81.11.1108.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2009.03.001"},{"key":"2026102613101477000_81.11.1108.45","doi-asserted-by":"crossref","first-page":"104023","DOI":"10.1016\/j.lpm.2020.104023","article-title":"Adult interstitial lung diseases and their epidemiology","volume":"49","author":"Ses\u00e9","year":"2020","journal-title":"Presse Med"},{"key":"2026102613101477000_81.11.1108.46","doi-asserted-by":"crossref","first-page":"427","DOI":"10.4103\/ijmr.ijmr_2360_22","article-title":"Risk factors for clinically significant diffuse parenchymal lung abnormalities persisting after severe COVID-19 pneumonia","volume":"157","author":"Dhooria","year":"2023","journal-title":"Indian J Med Res"},{"key":"2026102613101477000_81.11.1108.47","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02930-2021","article-title":"High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)","volume":"59","author":"Dhooria","year":"2022","journal-title":"Eur Respir J"},{"key":"2026102613101477000_81.11.1108.48","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4103\/lungindia.lungindia_568_21","article-title":"A multicenter survey study of antifibrotic use for symptomatic patients with post-COVID-19 interstitial lung abnormalities","volume":"39","author":"Dhooria","year":"2022","journal-title":"Lung India"},{"key":"2026102613101477000_81.11.1108.49","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2021-001049","article-title":"Understanding the burden of interstitial lung disease post-COVID-19: the UK Interstitial Lung Disease-Long COVID Study (UKILD-Long COVID)","volume":"8","author":"Wild","year":"2021","journal-title":"BMJ Open Resp Res"},{"key":"2026102613101477000_81.11.1108.50","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-065114","article-title":"Incidence and influencing factors of occupational pneumoconiosis: a systematic review and meta-analysis","volume":"13","author":"Su","year":"2023","journal-title":"BMJ Open"},{"key":"2026102613101477000_81.11.1108.51","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01669-2021"},{"key":"2026102613101477000_81.11.1108.52","unstructured":"Huang X , Liu W , Yao Y , et al . . China CDC Weekly 2023;5:856\u201360. 10.46234\/ccdcw2023.163"},{"key":"2026102613101477000_81.11.1108.53","doi-asserted-by":"crossref","first-page":"650","DOI":"10.47626\/1679-4435-2022-733","article-title":"Occupational characterization of workers exposed to asbestos: an integrative review","volume":"20","author":"Vicari","year":"2022","journal-title":"Rev Bras Med Trab"},{"key":"2026102613101477000_81.11.1108.54","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-022-14437-6","article-title":"A comparative study of the disease burden attributable to asbestos in Brazil, China, Kazakhstan, and Russia between 1990 and 2019","volume":"22","author":"Chen","year":"2022","journal-title":"BMC Public Health"},{"key":"2026102613101477000_81.11.1108.55","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5334\/aogh.3963","article-title":"Epidemiology of Asbestosis between 2010-2014 and 2015-2019 Periods in Colombia: Descriptive Study","volume":"89","author":"Camero","year":"2023","journal-title":"Ann Glob Health"},{"key":"2026102613101477000_81.11.1108.56","doi-asserted-by":"publisher","DOI":"10.1186\/1476-069X-4-24"},{"key":"2026102613101477000_81.11.1108.57","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15020384","article-title":"Australia\u2019s Ongoing Legacy of Asbestos: Significant Challenges Remain Even after the Complete Banning of Asbestos Almost Fifteen Years Ago","volume":"15","author":"Soeberg","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"2026102613101477000_81.11.1108.58","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2025.e42667","article-title":"Comparison of interstitial lung disease diagnoses in urban and rural areas among participants in the pulmonary fibrosis foundation patient registry","volume":"11","author":"Dimmock","year":"2025","journal-title":"Heliyon"},{"key":"2026102613101477000_81.11.1108.59","doi-asserted-by":"crossref","first-page":"107996","DOI":"10.1016\/j.rmed.2025.107996","article-title":"Geographic variability of interstitial lung disease diagnoses and impact of air pollution on disease outcomes","volume":"239","author":"Bagust","year":"2025","journal-title":"Respir Med"},{"key":"2026102613101477000_81.11.1108.60","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1908681"},{"key":"2026102613101477000_81.11.1108.61","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01575-2024"},{"key":"2026102613101477000_81.11.1108.62","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-021-01749-1","article-title":"Estimates of epidemiology, mortality and disease burden associated with progressive fibrosing interstitial lung disease in France (the PROGRESS study)","volume":"22","author":"Nasser","year":"2021","journal-title":"Respir Res"},{"key":"2026102613101477000_81.11.1108.63","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02718-2020"},{"key":"2026102613101477000_81.11.1108.64","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01786-8"},{"key":"2026102613101477000_81.11.1108.65","doi-asserted-by":"publisher","DOI":"10.1164\/RCCM.202205-0910LE"},{"key":"2026102613101477000_81.11.1108.66","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202201-0124OC"},{"key":"2026102613101477000_81.11.1108.67","doi-asserted-by":"crossref","first-page":"107656","DOI":"10.1016\/j.rmed.2024.107656","article-title":"Proportion and predictors of FVC decline in patients with interstitial lung disease","volume":"227","author":"Macmurdo","year":"2024","journal-title":"Respir Med"},{"key":"2026102613101477000_81.11.1108.68","doi-asserted-by":"crossref","first-page":"00597","DOI":"10.1183\/23120541.00597-2021","article-title":"Epidemiology of interstitial lung diseases and their progressive-fibrosing behaviour in six European countries","volume":"8","author":"Hilberg","year":"2022","journal-title":"ERJ Open Res"},{"key":"2026102613101477000_81.11.1108.69","first-page":"296","article-title":"Decreased Survival and Lung Function in Progressive Pulmonary Fibrosis","volume":"59","author":"Platenburg","year":"2023","journal-title":"Med Bogota Colomb"},{"key":"2026102613101477000_81.11.1108.70","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001901","article-title":"Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations","volume":"94","author":"Zhu","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"2026102613101477000_81.11.1108.71","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.chest.2022.04.001","article-title":"MUC5B Promoter Polymorphism and Survival in Indian Patients With Idiopathic Pulmonary Fibrosis","volume":"162","author":"Dhooria","year":"2022","journal-title":"Chest"},{"key":"2026102613101477000_81.11.1108.72","unstructured":"Dhooria S . 2025. Sarcoidosis: jaypee brothers medical publishers (p) ltd. 1165\u201394."},{"key":"2026102613101477000_81.11.1108.73","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00155-2020","article-title":"The opposite effect of human leukocyte antigen genotypes in sarcoidosis and tuberculosis: a narrative review of the literature","volume":"6","author":"Malkova","year":"2020","journal-title":"ERJ Open Res"},{"key":"2026102613101477000_81.11.1108.74","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1165\/rcmb.2014-0227OC","article-title":"Association of HLA-DRB1 with Sarcoidosis Susceptibility and Progression in African Americans","volume":"53","author":"Levin","year":"2015","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2026102613101477000_81.11.1108.75","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddad067"},{"key":"2026102613101477000_81.11.1108.76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/17476348.2023.2199156","article-title":"Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach","volume":"17","author":"Comes","year":"2023","journal-title":"Expert Rev Respir Med"},{"key":"2026102613101477000_81.11.1108.77","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1164\/rccm.201702-0400PP","article-title":"A Standardized Diagnostic Ontology for Fibrotic Interstitial Lung Disease. An International Working Group Perspective","volume":"196","author":"Ryerson","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026102613101477000_81.11.1108.78","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00032-2015","article-title":"Adherence to guidelines in idiopathic pulmonary fibrosis: a follow-up national survey","volume":"1","author":"Cottin","year":"2015","journal-title":"ERJ Open Res"},{"key":"2026102613101477000_81.11.1108.79","first-page":"30","article-title":"Knowledge, Attitudes, Beliefs and Practices of Physicians Regarding Idiopathic Pulmonary Fibrosis and the Impact of a Continuing Medical Education Program","volume":"65","author":"Dhooria","year":"2017","journal-title":"J Assoc Physicians India"},{"key":"2026102613101477000_81.11.1108.80","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.pulmoe.2020.05.017","article-title":"Translating Idiopathic pulmonary fibrosis guidelines into clinical practice","volume":"27","author":"Robalo-Cordeiro","year":"2021","journal-title":"Pulmonology"},{"key":"2026102613101477000_81.11.1108.81","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s44197-025-00377-y","article-title":"Shifting Trends in the Epidemiology and Management of Idiopathic Pulmonary Fibrosis in the Era of Evidence-Based Guidelines: a Nationwide Population Study","volume":"15","author":"Huang","year":"2025","journal-title":"J Epidemiol Glob Health"},{"key":"2026102613101477000_81.11.1108.82","doi-asserted-by":"crossref","first-page":"100334","DOI":"10.1016\/j.opresp.2024.100334","article-title":"Influence of Clinical Practice Guidelines on the Diagnosis and Treatment of Idiopathic Pulmonary Fibrosis. Data from the Registry of the Spanish Society of Pulmonology and Thoracic Surgery","volume":"6","author":"Aburto","year":"2024","journal-title":"Open Respir Arch"},{"key":"2026102613101477000_81.11.1108.83","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02163-2022","article-title":"Eligibility criteria from pharmaceutical randomised controlled trials of idiopathic pulmonary fibrosis: a registry-based study","volume":"61","author":"Khor","year":"2023","journal-title":"Eur Respir J"},{"key":"2026102613101477000_81.11.1108.84","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0201-2024","article-title":"Lack of diversity in antifibrotic trials for pulmonary fibrosis: a systematic review","volume":"34","author":"Pascoe","year":"2025","journal-title":"Eur Respir Rev"},{"key":"2026102613101477000_81.11.1108.85","unstructured":"Federal drug administration reports. Available: https:\/\/www.fda.gov\/media\/179593\/download [Accessed 12 Mar 2025]."},{"key":"2026102613101477000_81.11.1108.86","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-022-01922-2"},{"key":"2026102613101477000_81.11.1108.87","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s12325-020-01541-5","article-title":"Economic Burden and Management of Systemic Sclerosis-Associated Interstitial Lung Disease in 8 European Countries: The BUILDup Delphi Consensus Study","volume":"38","author":"Davidsen","year":"2021","journal-title":"Adv Ther"},{"key":"2026102613101477000_81.11.1108.88","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.201412-553OC"},{"key":"2026102613101477000_81.11.1108.89","doi-asserted-by":"crossref","first-page":"102071","DOI":"10.1016\/j.eclinm.2023.102071","article-title":"Drug therapies for treatment of idiopathic pulmonary fibrosis: a systematic review, Bayesian network meta-analysis, and cost-effectiveness analysis","volume":"61","author":"Zhao","year":"2023","journal-title":"eClinicalMedicine"},{"key":"2026102613101477000_81.11.1108.90","unstructured":"The World Health Organization Fact Sheets on Universal Heaklth Coverage. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/universal-health-coverage-(uhc) [Accessed 18 Mar 2025]."},{"key":"2026102613101477000_81.11.1108.91","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fpubh.2023.1041459","article-title":"Universal health coverage evolution, ongoing trend, and future challenge: A conceptual and historical policy review","volume":"11","author":"Ranabhat","year":"2023","journal-title":"Front Public Health"},{"key":"2026102613101477000_81.11.1108.92","unstructured":"Overview of medical service regime in Japan. Available: https:\/\/www.mhlw.go.jp\/bunya\/iryouhoken\/iryouhoken01\/dl\/01_eng.pdf [Accessed 11 Mar 2025]."},{"key":"2026102613101477000_81.11.1108.93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003651","article-title":"Moving toward universal health coverage with a national health insurance program: A scoping review and narrative synthesis of experiences in eleven low- and lower-middle income countries","volume":"5","author":"Flourence","year":"2025","journal-title":"PLOS Glob Public Health"},{"key":"2026102613101477000_81.11.1108.94","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/S2214-109X(23)00510-7","article-title":"The path to universal health coverage in five African and Asian countries: examining the association between insurance status and health-care use","volume":"12","author":"Odipo","year":"2024","journal-title":"Lancet Glob Health"},{"key":"2026102613101477000_81.11.1108.95","doi-asserted-by":"crossref","DOI":"10.1016\/j.lansea.2023.100180","article-title":"Evolution of Government-funded health insurance for universal health coverage in India","volume":"13","author":"Dubey","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"2026102613101477000_81.11.1108.96","doi-asserted-by":"crossref","first-page":"647","DOI":"10.3390\/ijerph21050647","article-title":"Improving Accessibility to Patients with Interstitial Lung Disease (ILD): Barriers to Early Diagnosis and Timely Treatment in Latin America","volume":"21","author":"Figueiredo","year":"2024","journal-title":"IJERPH"},{"key":"2026102613101477000_81.11.1108.97","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ccm.2021.03.013","article-title":"Care Delivery Models and Interstitial Lung Disease: The Role of the Specialized Center","volume":"42","author":"Fisher","year":"2021","journal-title":"Clin Chest Med"},{"key":"2026102613101477000_81.11.1108.98","doi-asserted-by":"crossref","unstructured":"Tikellis G , Holland AE . Health disparities and associated social determinants of health in interstitial lung disease: a narrative review. Eur Respir Rev 2025;34. doi:10.1183\/16000617.0176-2024","DOI":"10.1183\/16000617.0176-2024"},{"key":"2026102613101477000_81.11.1108.99","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s12890-017-0560-x","article-title":"Barriers to timely diagnosis of interstitial lung disease in the real world: the INTENSITY survey","volume":"18","author":"Cosgrove","year":"2018","journal-title":"BMC Pulm Med"},{"key":"2026102613101477000_81.11.1108.100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/s12931-019-1228-2","article-title":"Diagnostic test interpretation and referral delay in patients with interstitial lung disease","volume":"20","author":"Pritchard","year":"2019","journal-title":"Respir Res"},{"key":"2026102613101477000_81.11.1108.101","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-019-1076-0","article-title":"Risk factors for diagnostic delay in idiopathic pulmonary fibrosis","volume":"20","author":"Hoyer","year":"2019","journal-title":"Respir Res"},{"key":"2026102613101477000_81.11.1108.102","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2024-002333","article-title":"The diagnostic pathway for patients with interstitial lung disease: a mixed-methods study of patients and physicians","volume":"11","author":"Grant-Orser","year":"2024","journal-title":"BMJ Open Respir Res"},{"key":"2026102613101477000_81.11.1108.103","doi-asserted-by":"crossref","first-page":"00897","DOI":"10.1183\/23120541.00897-2020","article-title":"Idiopathic pulmonary fibrosis cluster analysis highlights diagnostic delay and cardiovascular comorbidity association with outcome","volume":"7","author":"Bordas-Mart\u00ednez","year":"2021","journal-title":"ERJ Open Res"},{"key":"2026102613101477000_81.11.1108.104","doi-asserted-by":"crossref","unstructured":"DeDent AM , Shore JE , Bascom R , et al . Caring for Rural Patients With Interstitial Lung Disease: Perspectives of Pulmonary Fibrosis Foundation Care Center Network Nurses and Providers. CHEST Pulmonary 2025;3. doi:10.1016\/j.chpulm.2025.100136","DOI":"10.1016\/j.chpulm.2025.100136"},{"key":"2026102613101477000_81.11.1108.105","doi-asserted-by":"publisher","DOI":"10.1016\/S1076-6332(03)80663-3"},{"key":"2026102613101477000_81.11.1108.106","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0191938","article-title":"Spectrum of interstitial lung diseases at a tertiary center in a developing country: A study of 803 subjects","volume":"13","author":"Dhooria","year":"2018","journal-title":"PLoS One"},{"key":"2026102613101477000_81.11.1108.107","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/crj.12734","article-title":"The safety and efficacy of different methods for obtaining transbronchial lung cryobiopsy in diffuse lung diseases","volume":"12","author":"Dhooria","year":"2018","journal-title":"Clin Respir J"},{"key":"2026102613101477000_81.11.1108.108","article-title":"Complication and cost analysis of transbronchial lung cryobiopsy and awake video-assisted thoracic surgery in diagnosis of interstitial lung disease","volume":"39","author":"Katgi","year":"2022","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026102613101477000_81.11.1108.109","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.arbres.2014.09.009","article-title":"Cryobiopsy in the diagnosis of diffuse interstitial lung disease: yield and cost-effectiveness analysis","volume":"51","author":"Hern\u00e1ndez-Gonz\u00e1lez","year":"2015","journal-title":"Arch Bronconeumol"},{"key":"2026102613101477000_81.11.1108.110","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1513\/AnnalsATS.202006-759OC","article-title":"Surgical Lung Biopsy for Interstitial Lung Disease. Safety and Feasibility at a Tertiary Referral Center","volume":"18","author":"Pastre","year":"2021","journal-title":"Ann Am Thorac Soc"},{"key":"2026102613101477000_81.11.1108.111","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/resp.14695","article-title":"Impact of surgical lung biopsy on lung function and survival in patients with idiopathic pulmonary fibrosis in a multi\u2010centre registry cohort","volume":"29","author":"Marcoux","year":"2024","journal-title":"Respirology"},{"key":"2026102613101477000_81.11.1108.112","doi-asserted-by":"crossref","first-page":"108216","DOI":"10.1016\/j.rmed.2025.108216","article-title":"Surgical lung biopsy for interstitial lung disease is a safe procedure in carefully selected patients","volume":"246","author":"Pande","year":"2025","journal-title":"Respir Med"},{"key":"2026102613101477000_81.11.1108.113","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/resp.14766","article-title":"Global challenges and disparities of care for interstitial lung disease","volume":"29","author":"Singh","year":"2024","journal-title":"Respirology"},{"key":"2026102613101477000_81.11.1108.114","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2024-002339","article-title":"Understanding facilitators and barriers to oxygen therapy for patients with interstitial lung disease","volume":"11","author":"Sharpe","year":"2024","journal-title":"BMJ Open Resp Res"},{"key":"2026102613101477000_81.11.1108.115","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01563-2018"},{"key":"2026102613101477000_81.11.1108.116","doi-asserted-by":"publisher","DOI":"10.1136\/bmjspcare-2019-002148"},{"key":"2026102613101477000_81.11.1108.117","doi-asserted-by":"crossref","first-page":"101227","DOI":"10.1016\/j.mam.2023.101227","article-title":"Pulmonary fibrosis: Emerging diagnostic and therapeutic strategies","volume":"94","author":"Selvarajah","year":"2023","journal-title":"Mol Aspects Med"},{"key":"2026102613101477000_81.11.1108.118","doi-asserted-by":"crossref","first-page":"191","DOI":"10.62347\/DAKS5508","article-title":"Cellular therapies for idiopathic pulmonary fibrosis: current progress and future prospects","volume":"13","author":"Le","year":"2024","journal-title":"Am J Stem Cells"},{"key":"2026102613101477000_81.11.1108.119","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s13287-025-04251-3","article-title":"Modeling of lung organoid-based fibrosis for testing the sensitivity of anti-fibrotic drugs","volume":"16","author":"Wang","year":"2025","journal-title":"Stem Cell Res Ther"},{"key":"2026102613101477000_81.11.1108.120","doi-asserted-by":"crossref","first-page":"11751","DOI":"10.3390\/ijms252111751","article-title":"In Vitro Modeling of Idiopathic Pulmonary Fibrosis: Lung-on-a-Chip Systems and Other 3D Cultures","volume":"25","author":"Corona","year":"2024","journal-title":"IJMS"},{"key":"2026102613101477000_81.11.1108.121","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/s12951-023-01971-7","article-title":"Inhaled nano-based therapeutics for pulmonary fibrosis: recent advances and future prospects","volume":"21","author":"Wan","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"2026102613101477000_81.11.1108.122","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13665-023-00334-9","article-title":"Artificial Intelligence in Chest Radiology: Advancements and Applications for Improved Global Health Outcomes","volume":"13","author":"Jalloul","year":"2024","journal-title":"Curr Pulmonol Rep"},{"key":"2026102613101477000_81.11.1108.123","first-page":"S4","article-title":"The Italian register for diffuse infiltrative lung disorders (RIPID): a four-year report","volume":"22 Suppl 1","author":"Tinelli","year":"2005","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2026102613101477000_81.11.1108.124","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2466-8-24","article-title":"The incidence of interstitial lung disease 1995-2005: a Danish nationwide population-based study","volume":"8","author":"Kornum","year":"2008","journal-title":"BMC Pulm Med"},{"key":"2026102613101477000_81.11.1108.125","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2013.09.002"},{"key":"2026102613101477000_81.11.1108.126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184548","article-title":"Estimating the incidence of interstitial lung diseases in the Cree of Eeyou Istchee, northern Qu\u00e9bec","volume":"12","author":"Storme","year":"2017","journal-title":"PLoS ONE"},{"key":"2026102613101477000_81.11.1108.127","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/resp.13234","article-title":"Co-morbidity and mortality among patients with interstitial lung diseases: A population-based study","volume":"23","author":"Hilberg","year":"2018","journal-title":"Respirology"},{"key":"2026102613101477000_81.11.1108.128","doi-asserted-by":"publisher","DOI":"10.1111\/crj.12035"},{"key":"2026102613101477000_81.11.1108.129","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-018-0660-2"},{"key":"2026102613101477000_81.11.1108.130","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s12890-023-02373-z","article-title":"Nationwide epidemiologic study for fibrosing interstitial lung disease (F-ILD) in South Korea: a population-based study","volume":"23","author":"Joung","year":"2023","journal-title":"BMC Pulm Med"},{"key":"2026102613101477000_81.11.1108.131","doi-asserted-by":"crossref","DOI":"10.1186\/s12890-019-0986-4","article-title":"Baseline characteristics and comorbidities in the CAnadian REgistry for Pulmonary Fibrosis","volume":"19","author":"Fisher","year":"2019","journal-title":"BMC Pulm Med"},{"key":"2026102613101477000_81.11.1108.132","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02571-2021","article-title":"Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry","volume":"60","author":"Hambly","year":"2022","journal-title":"Eur Respir J"},{"key":"2026102613101477000_81.11.1108.133","article-title":"Relative incidence of interstitial lung diseases in Brazil","volume":"50","author":"Matias","year":"2024","journal-title":"J Bras Pneumol"},{"key":"2026102613101477000_81.11.1108.134","first-page":"364","article-title":"First report of the Italian register for diffuse infiltrative lung disorders (RIPID)","volume":"56","author":"Agostini","year":"2001","journal-title":"Monaldi Arch Chest Dis"},{"key":"2026102613101477000_81.11.1108.135","doi-asserted-by":"publisher","DOI":"10.1055\/s-2003-40557"},{"key":"2026102613101477000_81.11.1108.136","article-title":"Pulmonary Fibrosis and Progressive Pulmonary Fibrosis in a Prospective Registry of Interstitial Lung Diseases in Eastern Siberia","volume":"13","author":"Nashatyreva","year":"2023","journal-title":"Life (Basel)"},{"key":"2026102613101477000_81.11.1108.137","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/1817-1737.105717","article-title":"Interstitial lung diseases in Saudi Arabia: A single-center study","volume":"8","author":"Alhamad","year":"2013","journal-title":"Ann Thorac Med"},{"key":"2026102613101477000_81.11.1108.138","doi-asserted-by":"crossref","first-page":"218","DOI":"10.5603\/PiAP.2014.0029","article-title":"Spectrum of Interstitial Lung Disease at a Tertiary Care Centre in India","volume":"82","author":"Kumar","year":"2014","journal-title":"Adv Respir Med"},{"key":"2026102613101477000_81.11.1108.139","first-page":"1065","article-title":"Spectrum of interstitial lung disease from a tertiary care hospital in Karachi","volume":"67","author":"Sarwar Zubairi","year":"2017","journal-title":"J Pak Med Assoc"},{"key":"2026102613101477000_81.11.1108.140","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01554-2017","article-title":"Spectrum of interstitial lung disease in China from 2000 to 2012","volume":"52","author":"Ban","year":"2018","journal-title":"Eur Respir J"},{"key":"2026102613101477000_81.11.1108.141","doi-asserted-by":"crossref","first-page":"365","DOI":"10.12669\/pjms.36.3.1046","article-title":"Epidemiology and Clinico-radiological features of Interstitial Lung Diseases","volume":"36","author":"Jafri","year":"2020","journal-title":"Pak J Med Sci"},{"key":"2026102613101477000_81.11.1108.142","doi-asserted-by":"crossref","first-page":"5","DOI":"10.4103\/lungindia.lungindia_414_20","article-title":"Survival predictors of interstitial lung disease in India: Follow-up of Interstitial Lung Disease India registry","volume":"38","author":"Singh","year":"2021","journal-title":"Lung India"},{"key":"2026102613101477000_81.11.1108.143","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-020-01297-2"},{"key":"2026102613101477000_81.11.1108.144","doi-asserted-by":"publisher","DOI":"10.1378\/chest.09-1002"},{"key":"2026102613101477000_81.11.1108.145","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/ajim.22719","article-title":"Silicosis prevalence and risk factors in semi-precious stone mining in Brazil","volume":"60","author":"Souza","year":"2017","journal-title":"Am J Ind Med"},{"key":"2026102613101477000_81.11.1108.146","doi-asserted-by":"crossref","first-page":"561","DOI":"10.13075\/ijomeh.1896.01950","article-title":"Epidemiology of silicosis reported to the central register of occupational diseases over last 20 years in Poland","volume":"35","author":"Nowak-Pasternak","year":"2022","journal-title":"Int J Occup Med Environ Health"},{"key":"2026102613101477000_81.11.1108.147","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/occmed\/kqz107","article-title":"Silicosis in rhinestone-manufacturing workers in South China","volume":"69","author":"Wen","year":"2019","journal-title":"Occup Med (Lond)"},{"key":"2026102613101477000_81.11.1108.148","doi-asserted-by":"crossref","first-page":"686","DOI":"10.4103\/jfmpc.jfmpc_1972_20","article-title":"Silicosis, progressive massive fibrosis and silico-tuberculosis among workers with occupational exposure to silica dusts in sandstone mines of Rajasthan state: An urgent need for initiating national silicosis control programme in India","volume":"10","author":"Nandi","year":"2021","journal-title":"J Family Med Prim Care"},{"key":"2026102613101477000_81.11.1108.149","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-020-08876-2","article-title":"Predictors of silicosis and variation in prevalence across mines among employed gold miners in South Africa","volume":"20","author":"Knight","year":"2020","journal-title":"BMC Public Health"},{"key":"2026102613101477000_81.11.1108.150","doi-asserted-by":"publisher","DOI":"10.1136\/oemed-2023-108892"}],"container-title":["Thorax"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/thorax-2025-223392","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T20:10:38Z","timestamp":1793045438000},"score":1,"resource":{"primary":{"URL":"https:\/\/thorax.bmj.com\/lookup\/doi\/10.1136\/thorax-2025-223392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,9]]},"references-count":150,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["10.1136\/thorax-2025-223392"],"URL":"https:\/\/doi.org\/10.1136\/thorax-2025-223392","relation":{},"ISSN":["0040-6376","1468-3296"],"issn-type":[{"value":"0040-6376","type":"print"},{"value":"1468-3296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,9]]}}}